Usage of ephedrine, norepinephrine and phenylephrine infusions to preventing A comparative hypotension in caesarian section(CS)

Comparative study between of ephedrine, norepinephrine and phenylephrine infusions to prevent spinal hypotension during cesarean section

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR201810518426098

Enrollment

Registered

2018-10-30

Start date

2018-10-13

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Phenylephrine group A

Nor epinephrine

Ephedrine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: ASA physical status I-II pregnant women, singleton gestation, >36 weeks, scheduled for elective cesarean section under regional anesthesia.

Exclusion criteria

Exclusion criteria: women who refuse to participate in the study, women with preeclampsia, eclampsia, cardiac patients, asthmatic patients any systemic diseases, patients with coagulation defects that contraindicate spinal anesthesia

Design outcomes

Primary

Measure	Time frame
comparing the effect of ephedrine, norepinephrine and phenylephrine infusions in preventing post-spinal hypotension	—

Secondary

Measure	Time frame
compare their effects on neonatal APGAR score, maternal nausea & vomiting	—

Countries

Egypt

Contacts

Public ContactAshraf Eskander

Assistant professor of anesthesia and intensive Care Faculty of Medicine Menoufia University

ameskander@yahoo.com00201001960697

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026